$ATOS 👇🏻👇🏻👇🏻. Just like Sam, been saying it all along, that Goetz should and, best case scenario, would be brought on as PI. Like Sgt., I agree it's clear that Atossa bought Goetz' data for that 1 mil. From Sam's email, it sounds like he will be the national PI of a US based trial to commence in 2022!
$ATOS I suspect he (Goetz) will be brought on to the steering committee of a US based clinical trial for Endoxifen...that takes Atossa to a whole new level in it's goal to replace the current gold standard for breast cancer therapy- Tamoxifen, with Endoxifen (a potent metabolite of tamoxifen that causes NO side effects- a MAJOR reason this will get fast-tracked with the FDA). 🍺🍺🍺💵💪🏼🔥
View original message